Consequently, the CRP and serum albumin ratio (CRP/Alb), a readily available marker reflecting inflammatory status, serves as an attractive indicator of cancer severity and prognosis, demonstrating prognostic value in several cancers, including hepatocellular, gastric, and esophageal squamous cell carcinoma [13-16]. Here, ALB is linked to cancer.